CLIP supports pre-clinical and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. CRI CLIP Grants are awarded to qualified scientists exploring clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies..
The Cancer Research Institute mission is to save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. It funds research aimed at furthering the development of immunological approaches to the diagnosis, treatment, and prevention of cancer.
The development of new and effective cancer treatment requires the translation of basic laboratory discoveries into novel therapies that can be tested in patients. This area of translational research—where laboratory findings move into clinical testing, and where questions from clinical studies are brought back into the lab—is critical to bringing new and better immunotherapies to patients.
The Cancer Research Institute established CLIP to support investigators who are studying critical topics at the intersection of laboratory and clinical research.
The deadline for the receipt of the Letter of Intent is December 1. Candidates will be notified by the end of January whether or not they have been invited to submit a full grant proposal. The full application is due March 1.
Candidates for a CRI CLIP Grant must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. If not, documentation from their institution must accompany the Letter of Intent indicating they will hold the position of assistant professor (or higher rank) by the time of award activation. CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools and research centers in the United States or abroad. Please note that CRI CLIP Grants do not support research at for-profit institutions.
CRI CLIP Grants provide up to $150,000 per year for two years. The funds may be used for salary, technical assistance, supplies, capital equipment, or scientific travel. CRI does not provide funds for indirect costs. Payments are made quarterly in U.S. currency to the host institution.
